MedPath

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

Not Applicable
Completed
Conditions
Substance Use
Interventions
Behavioral: Motivational Interviewing
Registration Number
NCT02495402
Lead Sponsor
RTI International
Brief Summary

To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.

Detailed Description

The Substance Abuse Treatment to HIV care (SAT2HIV) project, a Type 2 Effectiveness-Implementation Hybrid Trial, seeks to address this gap in services by providing new knowledge regarding the effectiveness of brief intervention (BI) for substance use within community-based HIV/AIDS service settings, as well as new knowledge regarding how to address the well-documented underutilization of evidence-based practices in real-world settings. The specific aims of this project are: Aim 1: To experimentally test the effectiveness of a motivational interviewing-based BI for substance use within community-based HIV/AIDS service organizations, relative to usual care (UC). Aim 2: To experimentally test the effectiveness of adding an organizational-level implementation intervention called Implementation \& Sustainment Facilitation (ISF) to enhance the effectiveness of the implementation strategy currently used by SAMHSA-funded Addiction Technology Treatment Centers (ATTCs; i.e., online introductory training, 2-day training workshop, ongoing feedback and coaching).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
827
Inclusion Criteria
  • Have HIV/AIDS.
  • Be 18 years of age or older.
  • Acknowledges use of at least one substance within the past 28 days and endorse 2+ substance use disorder symptoms during the past 12-months.
  • Provide signed and dated assurance of consent.
Exclusion Criteria
  • Are unable to speak English.
  • Are unwilling to allow brief intervention sessions to be audio recorded.
  • Are unwilling to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Motivational InterviewingMotivational InterviewingA brief interview intervention for substance abuse
Primary Outcome Measures
NameTimeMethod
Days of Primary Substance Use4 weeks post randomization

Days of Primary Substance Use - A continuous measure (ranges from 0 - 28) that is based on a question that asks participants to report how many days during the past 28 days they used their primary substance.

Number of Substance-related problems4 weeks post randomization

Number of Substance-related problems - A continuous measure (ranges from 0 - 11) that represents the sum of the number of 11 DSM-V substance use disorder symptoms participants report having occured during the past 28 days.

ART Medication Adherence4 weeks post randomization

ART Medication Adherence - A continuous measure (ranges from 0 -28) that is based on a question that asks participants to report how many days during the past 28 days that they have missed at least one dose of their HIV medications.

Times engaging in risky behaviors4 weeks post randomization

Times engaging in risky behaviors - A continuous measure (no specified range) that is based on a question that asks participants to report how many times during the past 28 days they engaged in unprotected sex, IV drug use, or needle sharing.

Days of Substance Use Treatment4 weeks post randomization

Days of Substance Use Treatment - A continuous measure (no specified range) that represents the sum of the number of days participants report going to residential treatment, outpatient treatment, or self-help group meetings during the past 28 days.

Secondary Outcome Measures
NameTimeMethod
Intentions to Change4 weeks post randomization

Intentions to Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals "Not at all" and 10 equals "The highest level possible" to indicate their intentions during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance.

Urgency to Change4 weeks post randomization

Urgency to Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals "Not at all" and 10 equals "The highest level possible" to indicate their urgency during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance.

Self-Efficacy to Change4 weeks post randomization

Self Efficacy for Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals "Not at all" and 10 equals "The highest level possible" to indicate their confidence during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance.

Commitment to Change4 weeks post randomization

Commitment to Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals "Not at all" and 10 equals "The highest level possible" to indicate their commitment during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance.

Trial Locations

Locations (39)

AIDS Project Greater Danbury, Inc.

🇺🇸

Danbury, Connecticut, United States

ARC Ohio (Collaborating Organization)

🇺🇸

Columbus, Ohio, United States

AIDS Foundation Houston

🇺🇸

Houston, Texas, United States

Minnesota AIDS Project (Collaborating Organization)

🇺🇸

Minneapolis, Minnesota, United States

Caracole House (Collaborating Organization)

🇺🇸

Cincinnati, Ohio, United States

Alamo Area Resource Center

🇺🇸

San Antonio, Texas, United States

Nashville CARES

🇺🇸

Nashville, Tennessee, United States

Shanti

🇺🇸

San Francisco, California, United States

Utah AIDS Foundation

🇺🇸

Salt Lake City, Utah, United States

HIV Care Directions

🇺🇸

Phoenix, Arizona, United States

Health Emergency Lifeline Programs (Collaborating Organization)

🇺🇸

Detroit, Michigan, United States

Community Health Awareness Group (Collaborating Organization)

🇺🇸

Detroit, Michigan, United States

Foothill AIDS Project

🇺🇸

Claremont, California, United States

AIDS Services Foundation, Orange County

🇺🇸

Irvine, California, United States

AIDS Project Los Angeles

🇺🇸

Los Angeles, California, United States

AIDS Connecticut, Inc

🇺🇸

Hartford, Connecticut, United States

Delaware HIV Consortium

🇺🇸

Wilmington, Delaware, United States

Project Response, Inc.

🇺🇸

Melbourne, Florida, United States

The Women's Collective

🇺🇸

Washington, District of Columbia, United States

Champaign-Urbana Public Health District (Collaborating Organization)

🇺🇸

Champaign, Illinois, United States

Live Forward (AIDS Athens)

🇺🇸

Athens, Georgia, United States

Southwest Louisiana AIDS Council

🇺🇸

Lake Charles, Louisiana, United States

AIDS Volunteers, Inc. (AVOL)

🇺🇸

Lexington, Kentucky, United States

The Project of the Quad Cities (Collaborating Organization)

🇺🇸

Davenport, Iowa, United States

AIDS Project Worcester

🇺🇸

Worcester, Massachusetts, United States

Doorways (Collaborating Organization)

🇺🇸

Saint Louis, Missouri, United States

Community AIDS Resources and Education Services (Collaborating Organization)

🇺🇸

Kalamazoo, Michigan, United States

Places for People (Collaborating Organization)

🇺🇸

Saint Louis, Missouri, United States

Project ARK

🇺🇸

Saint Louis, Missouri, United States

Nebraska AIDS Project (Collaborating Organization )

🇺🇸

Omaha, Nebraska, United States

St. Louis Effort for AIDS (Collaborating Organization)

🇺🇸

Saint Louis, Missouri, United States

Burrell Behavioral Health (Collaborating Organization)

🇺🇸

Springfield, Missouri, United States

Southern NH HIV/AIDS Task Force

🇺🇸

Nashua, New Hampshire, United States

AID Upstate

🇺🇸

Greenville, South Carolina, United States

HIV Alliance

🇺🇸

Eugene, Oregon, United States

Panhandle AIDS Support Organization

🇺🇸

Amarillo, Texas, United States

Triangle Area Network

🇺🇸

Beaumont, Texas, United States

Chattanooga CARES

🇺🇸

Chattanooga, Tennessee, United States

Vermont CARES

🇺🇸

Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath